Read the article
Read the article
Medicinal Oxygen: WHO International Pharmacopoeia PH.INT re-definition
A major milestone: Oxygen 93% is finally recognised as medically equivalent to Oxygen 99% / 99.5%
Concerns that the draft revision of the WHO International Pharmacopoeia would restrict access to medical oxygen are resolved. Past uncertainties caused by separate international definitions of medicinal oxygen dependant on concentration are thus eliminated. Healthcare Authorities, Hospitals and Healthcare Professionals working to the PH.INT definition can now treat patients with both oxygen 93% and oxygen 99.5% regardless of source.
We are sharing the on behalf of WHO International Pharmacopoeia, which defines and considers the following:
- The Medicinal Oxygen monograph now incorporates both currently internationally recognized concentrations of oxygen. Both Oxygen 93% and Oxygen 99.5% are hereby deemed medically equivalent in terms of patient treatment. The stipulated quality requirements are identical.
- In accordance with clinical guidelines, Medicinal Oxygen can be used either in undiluted form or as mixtures of Oxygen 93% and Oxygen 99.5%
A New Definition for WHO International Pharmacopoeia
This new definition comes as a result of in-depth consultation with globally recognized experts on the subject of patient treatment with Medicinal Oxygen. The WHO hereby drew on support from several key organizations including The Every Breath Counts Coalition https://stoppneumonia.org/, The World Federation of Societies of Anesthesiologists WFSAhttps://wfsahq.org/, ISO Technical Committee 121 (Anaesthetic and Respiratory Equipment)https://www.iso.org/committee/51984.html and the International Association of Manufacturers of Medical Gas Generators for Hospitals (MEDIGHAM) https://www.medigham.net/.
“The superior WHO definition of Medicinal Oxygen is a major milestone for PCI Gases as a recognized manufacturer of power-efficient onsite oxygen generators (DOCS). PCI Gases appreciates being afforded the opportunity to contribute to this WHO driven advance, thus removing one of the major barriers to patient access to life-saving medicinal oxygen worldwide. The specific listing of VSA technology for the first time in an international pharmacopeia further broadens the possibilities for Healthcare Authorities and Hospitals to select the oxygen source most suitable for specific local requirements and situations.”
Finally, the experts at the WHO are to be congratulated for taking a leading role in reducing barriers to Medicinal Oxygen, especially in Low and Middle Income Countries LMICs. Their fact-based amendment of PH.INT is both groundbreakingly vital and farsighted. As a direct result, innumerable patients will benefit from increased access to Medicinal Oxygen, alleviating suffering and saving lives throughout the world.
Open letter source: https://cdn.who.int/media/docs/default-source/essential-medicines/norms-and-standards/qas20-867-medicinal-oxygen.pdf?sfvrsn=ab60e2fe_5
Read more here:
https://www.pcigases.com/latest-news/pharmacopoeia-description-of-the-drugs-new-oxygen-monograph/
VSA Technology
To produce oxygen from air, PCI uses a proprietary Vacuum Swing Adsorption (VSA) process that eliminates many of the design problems associated with traditional on-site gas separation systems (PSA). Our innovative VSA system eliminates the need for process valves, feed air compressors, associated dryers and feed air filtering systems. Our robust VSA oxygen process extracts maximum sieve and power efficiencies = low cost (both CapX and OpX) high purity oxygen generation. Oxygen produced is 93% purity. Additional product/systems features include load following, remote monitoring and diagnostics along with an industry only 10-year warranty on the adsorber bed vessel. Average life span of our systems is 10-15+ years.
About PCI Gases
PCI Gases, headquartered in Riverside, California, is a global leader in advanced on-site gas generation systems. Specializing in Vacuum Swing Adsorption (VSA) technology for oxygen production, the company has been delivering innovative gas separation solutions since 1984. PCI Gases serves a wide range of industries, including medical, industrial, aquaculture, biogas, water treatment, and military applications.
With a mission to empower industries by providing autonomy in oxygen and nitrogen supply, PCI Gases helps clients reduce costs and improve sustainability. Their vision is to decentralize gas supply, offering economical and environmentally responsible solutions worldwide. Through a commitment to innovation and operational efficiency, PCI Gases continues to reshape industries and enhance the total cost of ownership for their customers.
Reshape Your Tomorrow!
For more information, contact the following person:
– Tim Boulton (Europe and Middle East): tb******@pc******.com
Posted August 31, 2022
